NCT00505401View on ClinicalTrials.gov

Phase I Safety and Immunogenicity Vaccine Trial Against HIV/AIDS

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

November 30, 2007

Conditions
HIV Infections
Interventions
BIOLOGICAL

recombinant HIV-1 Tat protein

Trial Locations (4)

20132

San Raffaele Hospital, Milan

00149

Hospital Spallanzani, Rome

00153

San Gallicano Hospital, Rome

00161

"University of Rome La Sapienza", Rome

All Listed Sponsors
lead

Istituto Superiore di Sanità

OTHER

NCT00505401 - Phase I Safety and Immunogenicity Vaccine Trial Against HIV/AIDS | Biotech Hunter | Biotech Hunter